{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:39:24Z","timestamp":1791941964026,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.015","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T23:32:38Z","timestamp":1458084758000},"page":"2066-2073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A recombinant DNA vaccine protects mice deficient in the alpha\/beta interferon receptor against lethal challenge with Usutu virus"],"prefix":"10.1016","volume":"34","author":[{"given":"Miguel A.","family":"Mart\u00edn-Acebes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Bel\u00e9n","family":"Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Ca\u00f1as-Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"V\u00e1zquez-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Merino-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Escribano-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Sobrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (9611)","key":"10.1016\/j.vaccine.2016.03.015_bib0255","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2016.03.015_bib0260","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMp1600297","article-title":"Zika virus in the Americas \u2013 yet another arbovirus threat","volume":"374","author":"Fauci","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.015_bib0265","doi-asserted-by":"publisher","unstructured":"Saiz JC, Vazquez-Calvo A, Blazquez AB, Merino-Ramos T, Escribano-Romero E, Martin-Acebes MA. Zika virus: the latest newcomer. Front Microbiol (In press).","DOI":"10.3389\/fmicb.2016.00496"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2016.03.015_bib0270","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1089\/vbz.2011.0631","article-title":"Usutu virus in Africa","volume":"11","author":"Nikolay","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2016.03.015_bib0275","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3201\/eid0807.020094","article-title":"Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe","volume":"8","author":"Weissenbock","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2016.03.015_bib0280","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3201\/eid1902.121191","article-title":"Usutu virus, Italy, 1996","volume":"19","author":"Weissenbock","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2016.03.015_bib0285","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/v7010219","article-title":"Usutu virus: an emerging flavivirus in Europe","volume":"7","author":"Ashraf","year":"2015","journal-title":"Viruses"},{"issue":"31","key":"10.1016\/j.vaccine.2016.03.015_bib0290","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.31.19935-en","article-title":"Usutu virus: potential risk of human disease in Europe","volume":"16","author":"Vazquez","year":"2011","journal-title":"Euro Surveill"},{"issue":"50","key":"10.1016\/j.vaccine.2016.03.015_bib0295","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.50.19448-en","article-title":"Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August\u2013September 2009","volume":"14","author":"Cavrini","year":"2009","journal-title":"Euro Surveill"},{"issue":"50","key":"10.1016\/j.vaccine.2016.03.015_bib0300","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.50.19446-en","article-title":"First human case of Usutu virus neuroinvasive infection, Italy, August\u2013September 2009","volume":"14","author":"Pecorari","year":"2009","journal-title":"Euro Surveill"},{"issue":"May","key":"10.1016\/j.vaccine.2016.03.015_bib0305","article-title":"First evidence of simultaneous occurrence of West Nile virus and Usutu virus neuroinvasive disease in humans in Croatia during the 2013 outbreak","author":"Vilibic-Cavlek","year":"2014","journal-title":"Infection"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2016.03.015_bib0310","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s13365-014-0300-4","article-title":"First cases of human Usutu virus neuroinvasive infection in Croatia, August\u2013September 2013: clinical and laboratory features","volume":"21","author":"Santini","year":"2015","journal-title":"J Neurovirol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2016.03.015_bib0315","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2016.03.015_bib0320","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2016.03.015_bib0325","doi-asserted-by":"publisher","first-page":"e108056","DOI":"10.1371\/journal.pone.0108056","article-title":"Protection of a single dose West Nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus","volume":"9","author":"Merino-Ramos","year":"2014","journal-title":"PLoS One"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2016.03.015_bib0330","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2016.03.015_bib0335","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1128\/JVI.77.7.4370-4382.2003","article-title":"Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus","volume":"77","author":"Lorenz","year":"2003","journal-title":"J Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2016.03.015_bib0340","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S1097-2765(01)00206-4","article-title":"Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus","volume":"7","author":"Ferlenghi","year":"2001","journal-title":"Mol Cell"},{"issue":"December (17)","key":"10.1016\/j.vaccine.2016.03.015_bib0345","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/0264-410X(95)00133-L","article-title":"Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis","volume":"13","author":"Heinz","year":"1995","journal-title":"Vaccine"},{"issue":"September (40)","key":"10.1016\/j.vaccine.2016.03.015_bib0350","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1016\/j.vaccine.2010.07.055","article-title":"Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate","volume":"28","author":"Ohtaki","year":"2010","journal-title":"Vaccine"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2016.03.015_bib0355","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1128\/JVI.74.9.4244-4252.2000","article-title":"A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice","volume":"74","author":"Chang","year":"2000","journal-title":"J Virol"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2016.03.015_bib0360","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00401-004-0916-1","article-title":"Experimental Usutu virus infection of suckling mice causes neuronal and glial cell apoptosis and demyelination","volume":"108","author":"Weissenbock","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.vaccine.2016.03.015_bib0365","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.virol.2015.03.020","article-title":"Limited susceptibility of mice to Usutu virus (USUV) infection and induction of flavivirus cross-protective immunity","volume":"482","author":"Blazquez","year":"2015","journal-title":"Virology"},{"issue":"June (5167)","key":"10.1016\/j.vaccine.2016.03.015_bib0370","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2016.03.015_bib0375","first-page":"301","article-title":"Complete genome analysis and molecular characterization of Usutu virus that emerged in Austria in 2001: comparison with the South African strain SAAR-1776 and other flaviviruses","volume":"328","author":"Bakonyi","year":"2004","journal-title":"Virology"},{"issue":"April (Pt 4)","key":"10.1016\/j.vaccine.2016.03.015_bib0380","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1099\/vir.0.027185-0","article-title":"A West Nile virus mutant with increased resistance to acid-induced inactivation","volume":"92","author":"Martin-Acebes","year":"2011","journal-title":"J Gen Virol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2016.03.015_bib0385","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1128\/JVI.02311-09","article-title":"A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition","volume":"84","author":"Martin-Acebes","year":"2010","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.03.015_bib0390","doi-asserted-by":"publisher","first-page":"e2509","DOI":"10.1371\/journal.pntd.0002509","article-title":"Infection with Usutu virus induces an autophagic response in mammalian cells","volume":"7","author":"Blazquez","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2016.03.015_bib0395","doi-asserted-by":"publisher","first-page":"e24970","DOI":"10.1371\/journal.pone.0024970","article-title":"West Nile virus replication requires Fatty Acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids","volume":"6","author":"Martin-Acebes","year":"2011","journal-title":"PLoS One"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2016.03.015_bib0400","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/JVI.70.7.4549-4557.1996","article-title":"Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions","volume":"70","author":"Schalich","year":"1996","journal-title":"J Virol"},{"issue":"September (1\u20132)","key":"10.1016\/j.vaccine.2016.03.015_bib0405","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0166-0934(01)00346-9","article-title":"A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen","volume":"97","author":"Hunt","year":"2001","journal-title":"J Virol Methods"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2016.03.015_bib0410","doi-asserted-by":"publisher","first-page":"13262","DOI":"10.1128\/JVI.79.21.13262-13274.2005","article-title":"N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity","volume":"79","author":"Hanna","year":"2005","journal-title":"J Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2016.03.015_bib0415","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/elps.11501401163","article-title":"The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences","volume":"14","author":"Bjellqvist","year":"1993","journal-title":"Electrophoresis"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.015_bib0420","doi-asserted-by":"publisher","first-page":"e8325","DOI":"10.1371\/journal.pone.0008325","article-title":"Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins","volume":"4","author":"Wang","year":"2009","journal-title":"PLoS One"},{"issue":"August\u2013October (2\u20133)","key":"10.1016\/j.vaccine.2016.03.015_bib0425","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jcpa.2004.03.004","article-title":"Pathology and viral distribution in fatal Usutu virus infections of birds from the 2001 and 2002 outbreaks in Austria","volume":"131","author":"Chvala","year":"2004","journal-title":"J Comp Pathol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2016.03.015_bib0430","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3201\/eid1907.130199","article-title":"Usutu virus in migratory song thrushes, Spain","volume":"19","author":"Hofle","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2016.03.015_bib0435","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.3390\/v5123088","article-title":"West Nile virus in the United States \u2013 a historical perspective","volume":"5","author":"Roehrig","year":"2013","journal-title":"Viruses"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2016.03.015_bib0440","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/trstmh\/trv066","article-title":"A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap?","volume":"109","author":"Nikolay","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"August","key":"10.1016\/j.vaccine.2016.03.015_bib0445","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virol.2015.07.015","article-title":"Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses","volume":"485","author":"Cacciotti","year":"2015","journal-title":"Virology"},{"issue":"April (Pt 4)","key":"10.1016\/j.vaccine.2016.03.015_bib0450","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1099\/vir.0.046433-0","article-title":"Usutu virus growth in human cell lines: induction of and sensitivity to type I and III interferons","volume":"94","author":"Scagnolari","year":"2013","journal-title":"J Gen Virol"},{"issue":"April","key":"10.1016\/j.vaccine.2016.03.015_bib0455","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2014.12.001","article-title":"New insights into innate immune restriction of West Nile virus infection","volume":"11","author":"Lazear","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2016.03.015_bib0460","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jmb.2013.11.023","article-title":"Innate immunity to dengue virus infection and subversion of antiviral responses","volume":"426","author":"Green","year":"2014","journal-title":"J Mol Biol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2016.03.015_bib0465","doi-asserted-by":"publisher","first-page":"e0003579","DOI":"10.1371\/journal.pntd.0003579","article-title":"Immunization of knock-out alpha\/beta interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine","volume":"9","author":"Canakoglu","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2016.03.015_bib0470","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1128\/JVI.01320-14","article-title":"A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease","volume":"89","author":"Sarathy","year":"2015","journal-title":"J Virol"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2016.03.015_bib0475","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.vaccine.2009.10.027","article-title":"Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(\u2212\/\u2212) mice against lethal bluetongue infection","volume":"28","author":"Calvo-Pinilla","year":"2009","journal-title":"Vaccine"},{"issue":"January (12)","key":"10.1016\/j.vaccine.2016.03.015_bib0480","article-title":"A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available","volume":"32","author":"Ishikawa","year":"2014","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2016.03.015_bib0485","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2016.03.015_bib0490","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1586\/erv.11.180","article-title":"Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex","volume":"11","author":"Lobigs","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.03.015_bib0495","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"issue":"December","key":"10.1016\/j.vaccine.2016.03.015_bib0500","article-title":"The interplay of dengue virus morphological diversity and human antibodies","author":"Lok","year":"2015","journal-title":"Trends Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16003157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16003157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T05:16:42Z","timestamp":1655270202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16003157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":50,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16003157"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recombinant DNA vaccine protects mice deficient in the alpha\/beta interferon receptor against lethal challenge with Usutu virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}